Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Otto

Showing results (331-340 of 632) with videos related to

Pageof 64
Sort By:
JAMA|September 8, 1989
End-tidal carbon dioxide monitoring during cardiopulmonary resuscitation. A prognostic indicator for survivalA B Sanders, K B Kern, C W Otto, et al.
Aktuelle Urologie|February 10, 2007
[Operative treatment of female urinary incontinence with particular consideration of sexuality according to anatomical findings]T Otto, K Bornemeyer, J W Bagner, et al.
Pharmacology, Biochemistry, and Behavior|December 8, 2010
Cognitive enhancers for anxiety disordersStefan G Hofmann, Jasper A J Smits, Anu Asnaani, et al.
The Journal of Nervous and Mental Disease|February 8, 2006
Do baseline client characteristics predict the therapeutic alliance in the treatment of schizophrenia?Shannon M Couture, David L Roberts, David L Penn, et al.
Aktuelle Urologie|January 30, 2008
[Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?]S Denzinger, M Burger, H-M Fritsche, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 22, 2010
Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010W Otto, A Mankertz, S Santibanez, et al.
Journal of Anxiety Disorders|February 19, 2009
Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentationMark B Powers, Jasper A J Smits, Michael W Otto, et al.
The American Journal on Addictions|March 30, 2018
Substance use comorbidity in bipolar disorder: A qualitative review of treatment strategies and outcomesAlexandra K Gold, Michael W Otto, Thilo Deckersbach, et al.
Expert Review of Neurotherapeutics|September 26, 2012
Exploring exercise as an avenue for the treatment of anxiety disordersLindsey B DeBoer, Mark B Powers, Angela C Utschig, et al.
Journal of Anxiety Disorders|August 16, 2005
Rates of isolated sleep paralysis in outpatients with anxiety disordersMichael W Otto, Naomi M Simon, Mark Powers, et al.
Pageof 64

Showing results (331-340 of 632) with videos related to

Sort By:
Pageof 64
JAMA|September 8, 1989
End-tidal carbon dioxide monitoring during cardiopulmonary resuscitation. A prognostic indicator for survivalA B Sanders, K B Kern, C W Otto, et al.
Aktuelle Urologie|February 10, 2007
[Operative treatment of female urinary incontinence with particular consideration of sexuality according to anatomical findings]T Otto, K Bornemeyer, J W Bagner, et al.
Pharmacology, Biochemistry, and Behavior|December 8, 2010
Cognitive enhancers for anxiety disordersStefan G Hofmann, Jasper A J Smits, Anu Asnaani, et al.
The Journal of Nervous and Mental Disease|February 8, 2006
Do baseline client characteristics predict the therapeutic alliance in the treatment of schizophrenia?Shannon M Couture, David L Roberts, David L Penn, et al.
Aktuelle Urologie|January 30, 2008
[Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?]S Denzinger, M Burger, H-M Fritsche, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 22, 2010
Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010W Otto, A Mankertz, S Santibanez, et al.
Journal of Anxiety Disorders|February 19, 2009
Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentationMark B Powers, Jasper A J Smits, Michael W Otto, et al.
The American Journal on Addictions|March 30, 2018
Substance use comorbidity in bipolar disorder: A qualitative review of treatment strategies and outcomesAlexandra K Gold, Michael W Otto, Thilo Deckersbach, et al.
Expert Review of Neurotherapeutics|September 26, 2012
Exploring exercise as an avenue for the treatment of anxiety disordersLindsey B DeBoer, Mark B Powers, Angela C Utschig, et al.
Journal of Anxiety Disorders|August 16, 2005
Rates of isolated sleep paralysis in outpatients with anxiety disordersMichael W Otto, Naomi M Simon, Mark Powers, et al.
Pageof 64